Effect of oxygenated polyethylene glycol decorated hemoglobin on microvascular diameter and functional capillary density in the transgenic mouse model of sickle cell anemia

References

• Acharya AS, Manjula BN, Smith P, . 1996. Hemoglobin crosslinkers. US Patent number. 5:585–484.
   Google Scholar
• Aslan M, Ryan TM, Adler B, Townes TM, Parks DA, Thompson JA, et al. 2001. Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. PNAS. 98:15215–15220.
   PubMed Web of Science ®Google Scholar
• Belcher JD, Bryant CJ, Nguyen J, Bowlin PR, Kielbik MC, Bischof JC, et al. 2003. Transgenic sickle mice have vascular inflammation. Blood. 101:3953–3959.
   PubMed Web of Science ®Google Scholar
• Belcher JD, Young MA, Chen C, Nguyen J, Burhop K, Tran P, Vercellotti GM. 2013. MP4CO, a pegylated hemoglobin saturated with carbon monoxide, is a modulator of HO-1, inflammation, and vaso-occlusion in transgenic sickle mice. Blood. 122:2757–2764.
   PubMed Web of Science ®Google Scholar
• Cabrales P, Tsai AG, Frangos JA, Intaglietta M. 2005a. Role of endothelial nitric oxide in microvascular oxygen delivery and consumption. Free Radic Biol Med. 39:1229–1237.
   PubMed Web of Science ®Google Scholar
• Cabrales P, Tsai AG, Intaglietta M. 2004. Microvascular pressure and functional capillary density in extreme hemodilution with low and high plasma viscosity expanders. Am J Physiol. 287:H363–H373.
   Web of Science ®Google Scholar
• Cabrales P, Tsai AG, Winslow RM, Intaglietta M. 2005b. Effects of extreme hemodilution with hemoglobin based O2 carriers on microvascular pressure. Am J Physiol. 288:H2146–H2153.
   Web of Science ®Google Scholar
• Crawford MW, Shichor T, Engelhardt T, Adamson G, Bell D, Carmichael FJ, Kim PC. 2007. The novel hemoglobin-based oxygen carrier HRC 101 improves survival in murine sickle cell disease. Anesthesiology. 107:281–287.
   PubMed Web of Science ®Google Scholar
• Dong C, Chadwick RS, Schechter AN. 1992. Influence of sickle hemoglobin polymerization and membrane properties on deformability of sickle erythrocytes in the microcirculation. Biophys J. 63:774–783.
   PubMed Web of Science ®Google Scholar
• Drobin D, Kjellstrom BT, Malm E, Malavalli A, Lohman L, Vandegriff KD, et al. 2004. Hemodynamic response and oxygen transport in pigs resuscitated with maleimide-polyethylene glycol-modified hemoglobin (MP4). J Appl Physiol. 96:1843–1853.
   PubMed Web of Science ®Google Scholar
• Embury SH, Matsui NM, Ramanujam S, Mayadas TN, Noguchi CT, Diwan BA, et al. 2004. The contribution of endothelial cell P-selectin to the microvascular flow of mouse sickle erythrocytes in vivo. Blood. 104:3378–3385.
   PubMed Web of Science ®Google Scholar
• Embury SH, Mohandas N, Paszty C, Cooper P, Cheung AT. 1999. In vivo blood flow abnormalities in the transgenic knockout sickle cell mouse. J Clin Invest. 103:915–920.
   PubMed Web of Science ®Google Scholar
• Feola M, Simoni J, Angelillo R, Luhruma Z, Kabakele M, Manzombi M, Kaluila M. 1992. Clinical trial of a hemoglobin based blood substitute in patients with sickle cell anemia. Surg Gynecol Obstet. 174:379–386.
   PubMedGoogle Scholar
• Gladwin MT, Crawford JH, Patel RP. 2004. The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation. Free Radic Biol Med. 36:707–717.
   PubMed Web of Science ®Google Scholar
• Gonzalez P, Hackney AC, Jones S, Strayhorn D, Hoffman EB, Hughes G, et al. 1997. A phase I/II study of polymerized bovine hemoglobin in adult patients with sickle cell disease not in crisis at the time of study. J Investig Med. 45:258–264.
   PubMed Web of Science ®Google Scholar
• Intaglietta M, Tompkins WR. 1973. Microvascular measurements by video image shearing and splitting. Microvasc Res. 5:309–312.
   PubMed Web of Science ®Google Scholar
• Kalambur VS, Mahaseth H, Bischof JC, Kielbik MC, Welch TE, Vilback A, et al. 2004. Microvascular blood flow and stasis in transgenic sickle mice: utility of a dorsal skin fold chamber for intravital microscopy. Am J Hematol. 77:117–125.
   PubMed Web of Science ®Google Scholar
• Kaul DK, Fabry ME. 2004. In vivo studies of sickle red blood cells. Microcirculation. 11:153–165.
   PubMed Web of Science ®Google Scholar
• Kaul DK, Fabry ME, Nagel RL. 1996. The pathophysiology of vascular obstruction in the sickle syndromes. Blood Rev. 10:29–44.
   PubMed Web of Science ®Google Scholar
• Kaul DK, Hebbel RP. 2000. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest. 106:411–420.
   PubMed Web of Science ®Google Scholar
• Kaul DK, Liu X, Nagel RL. 2001. Ameliorating effects of fluorocarbon emulsion on sickle red blood cell-induced obstruction in an ex vivo vasculature. Blood. 98:3128–3131.
   PubMed Web of Science ®Google Scholar
• Klug PP, Kaye N, Jensen WN. 1982. Endothelial cell and vascular damage in the sickle cell disorders. Blood Cells. 8:175–84.
   PubMedGoogle Scholar
• Lehr HA, Leunig M, Menger MD, Nolte D, Messmer K. 1993. Dorsal skinfold chamber technique for intravital microscopy in nude mice. Am J Pathol. 143:1055–1062.
   PubMed Web of Science ®Google Scholar
• Li J, Kim K, Hahm E, Molokie R, Hay N, Gordeuk VR, et al. 2014. Neutrophil AKT regulates heterotypic cell-cell interactions during vascular inflammation. J Clin Invest. 124:1483–1496.
   PubMed Web of Science ®Google Scholar
• Lipowsky HH, Sheikh NU, Katz DM. 1987. Intravital microscopy of capillary hemodynamics in sickle cell disease. J Clin Invest. 80:117–127.
   PubMed Web of Science ®Google Scholar
• National Research Council. Guide for the Care and Use of Laboratory Animals: Eighth Edition.Washington, DC: The National Academies Press. 2011.
   Google Scholar
• Oliva ME. 2005. The effect of Oxy-MP4, CO-MP4 and DPTA on the filterability of sickle cell red blood cells during continuous deoxygenation [Thesis]. M.S., University of California, San Diego.
   Google Scholar
• Orringer E, Gonzalez P, Hackney A, Jones SK, Hoffman EB, Jacobs EE, Hughes GS. 1995. A phase I study of polymerized bovine hemoglobin (PBH) in adult patients with sickle cell disease not in crisis at the time of study. In: Beuzard Y, Lubin B, Ross J, Eds. Sickle Cell Disease and Thalassemias: New Trends in Therapy. Montrogue, France: Colloque INSERM/John Libbey Eurotext Ldt., pp. 301–302.
   Google Scholar
• Osarogiagbon UR, Choong S, Belcher JD, Vercellotti GM, Paller MS, Hebbel RP. 2000. Reperfusion injury pathophysiology in sickle transgenic mice. Blood. 96:314–320.
   PubMed Web of Science ®Google Scholar
• Platt OS. 2000. Sickle cell anemia as an inflammatory disease. J Clin Invest. 106:337–338.
   PubMed Web of Science ®Google Scholar
• Reiter CD, Wang X, Tanus-Santos JE, Hogg N, Cannon RO III, Schechter AN, Gladwin MT. 2002. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med. 8: 1383–1389.
   PubMed Web of Science ®Google Scholar
• Rodgers GP, Schechter AN, Noguchi CT, Klein HG, Nienhuis AW, Bonner RF. 1990. Microcirculatory adaptations in sickle cell anemia: reactive hyperemia response. Am J Physiol Heart Circ Physiol. 258:H113–120.
   Web of Science ®Google Scholar
• Ryan TM, Ciavatta DJ, Townes TM. 1997. Knockout-transgenic mouse model of sickle cell disease. Science. 278:873–876.
   PubMed Web of Science ®Google Scholar
• Tsai AG, Cabrales P, Manjula BN, Acharya SA, Winslow RM, Intaglietta M. 2006. Dissociation of local nitric oxide concentration and vasoconstriction in the presence of cell-free hemoglobin oxygen carriers. Blood. 108:3603–3610.
   PubMed Web of Science ®Google Scholar
• Tsai AG, Vandegriff KD, Intaglietta M, Winslow RM. 2003. Targeted O2 delivery by low-P50 hemoglobin: a new basis for O2 therapeutics. Am J Physiol Heart Circ Physiol. 285:H1411–H1419.
   PubMed Web of Science ®Google Scholar
• Vandegriff KD, Bellelli A, Samaja M, Malavalli A, Brunori M, Winslow RM. 2004. Kinetics of NO and O2 binding to a maleimide poly(ethylene glycol)-conjugated human haemoglobin. Biochem J. 382:183–189.
   PubMed Web of Science ®Google Scholar
• Vandegriff KD, Malavalli A, Woodridge J, Lohman J, Winslow RM. 2003. MP4, a new nonvasoactive PEG-Hb conjugate. Transfusion. 43:509–516.
   PubMed Web of Science ®Google Scholar
• Vercellotti GM, Belcher JD. 2014. Not simply misshapen red cell: multimulecular and cellular events in sickle vasoocclusion. J Clin Invest. 124:1462–1465.
   PubMed Web of Science ®Google Scholar
• Winslow RM, Intaglietta M, Tsai AG, Vandegriff KD, Wettstein R. 2002. Autoregulation and vasoconstriction: foundation for a new generation of blood substitutes. Blood. 100:210.
   Google Scholar
• Winslow RM, Lohman J, Malavalli A, Vandegriff KD. 2004. Comparison of PEG-modified albumin and hemoglobin in extreme hemodilution in the rat. J Appl Physiol. 97:1527–1534.
   PubMed Web of Science ®Google Scholar
• Yabuki A, Matsushita M, Malchesky P, Iwasaki K, Iwashita Y, Nose Y. 1988. In vitro evaluation of a pyridoxalated hemoglobin polyoxyethylene conjugated in reversing cell sickling. ASAIO Trans. 773–777.
   PubMedGoogle Scholar